NCT05018728 - The Effect of Voxelotor on Cerebral Hemodynamic Response in Children with Sickle Cell Anemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 28, 2022

Primary Completion Date

October 22, 2024

Study Completion Date

October 22, 2024

Conditions

Sickle Cell Anemia in Children

Interventions

DRUG

Voxelotor

Voxelotor is taken orally once a day. Participants 12 years or older will take 1500 mg/day. Participants younger than 12 years of age will receive a dose based on their body weight to provide exposure corresponding to the adult dose of 1500 mg/day.

Trial Locations (2)

30322

Children's Healthcare of Atlanta, Atlanta

30342

Aflac Sickle Cell Comprehensive Clinics at Children's Healthcare of Atlanta, Scottish Rite, Atlanta